NCT03050580 is a NA clinical trial of self-esteem enhancement group in Abused Women, sponsored by The University of Hong Kong.

Who is sponsoring NCT03050580?

NCT03050580 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT03050580?

Interventions in NCT03050580: self-esteem enhancement group, Standard care for abused women.

What condition does NCT03050580 study?

NCT03050580 studies Abused Women.

Is NCT03050580 still recruiting?

NCT03050580 is currently completed. Last updated 13 February 2017.

Last reviewed 2017-02-13 · How we verify

NCT03050580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Evaluation of the "Treatment Group Model for Abused Women" in Shelters in Hong Kong

Completed NA Last updated 13 February 2017

What this trial tests

NA trial testing self-esteem enhancement group in Abused Women in 122 participants. Completed in 30 June 2015.

Timeline

1 January 2013

Primary endpoint
30 November 2014

30 June 2015

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	122
Start date	1 January 2013
Primary completion	30 November 2014
Estimated completion	30 June 2015

Drugs / interventions tested

self-esteem enhancement group
Standard care for abused women

Conditions studied

Abused Women — all drugs for Abused Women →

Sponsor

The University of Hong Kong

Who can join

18 and older, female only, with Abused Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is cluster randomized control trial, that aims to evaluate the effectiveness of the treatment group model for abused women in enhancing their self-esteem and reducing the level of depression, in three shelters for abused women of Po Leung Kuk (a social service organization in Hong Kong). It is hypothesized that subjects in the Treatment Group would report significant improvement in self-esteem, social support, quality of life; reduction in the level of depression, symptoms of Posttraumatic Stress Disorder at 3 months after service delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03050580 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 13 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03050580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing